Boston Cell Standards
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
800 Washington Street Ziskind 417, Bosto...Phone Number
(617) 636-8042Website
www.bostoncellstandards.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Boston Cell Standards
Boston Cell Standards specializes in providing calibration and statistical process control solutions for immunohistochemistry (IHC) testing, ensuring accurate cancer diagnosis and treatment decisions. Their products, including IHCalibrators and IHControls, are designed for clinical testing labs and the pharmaceutical/life sciences sector, addressing the challenges of testing accuracy and consistency. The company collaborates with organizations like the FDA and NIST to enhance IHC testing standards and has received significant funding from the National Cancer Institute. Boston Cell Standards is committed to improving IHC practices through innovative solutions and educational resources.Explore more
Boston Cell Standards Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Boston Cell Standards your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Boston Cell Standards is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Boston Cell Standards, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Boston Cell Standards had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Boston Cell Standards has new funding data
Congratulate Masked Content for being promoted to Masked Content at Boston Cell Standards
Product Launch: Get notified when Boston Cell Standards launches new products
Check if Boston Cell Standards has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Boston Cell Standards recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Boston Cell Standards as Masked Content
Find 2 more new buyers
Compare Similar Companies to Boston Cell Standards
Compare insights from companies similar to Boston Cell Standards, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Boston Cell Standards is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Boston Cell Standards is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Boston Cell Standards.
Boston Cell Standards financials insights
Gather financial insights about Boston Cell Standards, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$52K
Boston Cell Standards Tech Stack
A closer look at the technologies used by Boston Cell Standards
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Boston Cell Standards is planning to move its offices in January 2024. The move will impact approximately 8 employees at their existing office located at 800 Washington Street, Ziskind 417, Boston, MA.
Project
Award
Funding
Boston Cell Standards has received an SBA PPP loan in the amount of $52,623 from Avidia Bank resulting in the retention of 4 jobs.
Funding
Boston Cell Standards News & Media
Visiopharm and Boston Cell Standards Announce Partnership to Develop Joint IHC Technology for Magnani-Taylor Regulatory Proposal
COPENHAGEN, Denmark & BOSTON--(BUSINESS WIRE)-- #biotech--Visiopharm and Boston Cell Standards today announced a partnership to develop a joint technology solution that enables labs to meet key provisions of regulatory changes proposed in a groundbreaking editorial recently published in Archives of Pathology & Laboratory Medicine. In a July 2023 Archives online editorial, Dr. Barbarajean Magnani and Dr. Clive Taylor proposed that clinical immunohistochemistry (IHC) quality assurance requirementsBoston Cell Standards Wins First-Ever FDA 510(k) Clearance for Anatomic Pathology Controls
BOSTON--(BUSINESS WIRE)-- #cancerdiagnostics--Boston Cell Standards, a company standardizing cancer diagnostic tissue testing with the first immunohistochemistry (IHC) laboratory reference standards, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for its IHControls® panel (HER2/ER/PR) for evaluating breast cancers. This clearance represents a first-in-category regulatory approval. IHControls are the first truly quantitative linear range controls for IHC labPublication Describes New International Consortium Standardizing Immunohistochemistry
BOSTON--(BUSINESS WIRE)-- #biotech--Boston Cell Standards, a company standardizing tumor tissue testing with the first immunohistochemistry laboratory reference standards, announced the publication of a journal article summarizing the vital mission of the newly launched Consortium for Analytic Standardization in Immunohistochemistry (CASI). In the article, “A Consortium for Analytic Standardization in Immunohistochemistry[i],” published online in the Archives of Pathology & Laboratory Medicine,Study Establishes Boston Cell Standards’ Calibrated IHC Technology for Companion Diagnostic Immunohistochemistry
BOSTON--(BUSINESS WIRE)--Boston Cell Standards has announced a study and editorial in Modern Pathology supporting its cIHC technology for companion diagnostic testing.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Boston Cell Standards
Sign Up For FreeTo access detailed company insights
Boston Cell Standards specializes in providing calibration and statistical process control solutions for immunohistochemistry (IHC) testing, ensuring accurate cancer diagnosis and treatment decisions. Their products, including IHCalibrators and IHControls, are designed for clinical testing labs and the pharmaceutical/life sciences sector, addressin... Read More
